Corient Private Wealth’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36M Buy
50,132
+5,902
+13% +$432K ﹤0.01% 1069
2026
Q1
$3.16M Buy
44,230
+4,562
+12% +$329K ﹤0.01% 1030
2025
Q4
$2.53M Sell
39,668
-1,599
-4% -$98.5K ﹤0.01% 1037
2025
Q3
$2.6M Sell
41,267
-4,253
-9% -$297K ﹤0.01% 954
2025
Q2
$3.4M Sell
45,520
-2,871
-6% -$226K ﹤0.01% 831
2025
Q1
$4.26M Sell
48,391
-26,018
-35% -$2.46M 0.01% 726
2024
Q4
$6.5M Sell
74,409
-12,688
-15% -$1.3M 0.01% 629
2024
Q3
$9.75M Sell
87,097
-4,302
-5% -$430K 0.02% 573
2024
Q2
$8.95M Buy
91,399
+282
+0.3% +$28K 0.02% 558
2024
Q1
$9.13M Sell
91,117
-8,093
-8% -$712K 0.02% 547
2023
Q4
$8.91M Buy
99,210
+48,762
+97% +$3.89M 0.02% 546
2023
Q3
$3.87M Sell
50,448
-4,178
-8% -$347K 0.01% 696
2023
Q2
$4.57M Sell
54,626
-1,454
-3% -$118K 0.01% 655
2023
Q1
$4.73M Buy
56,080
+3,559
+7% +$306K 0.01% 612
2022
Q4
$4.28M Buy
+52,521
New +$4.23M 0.02% 534

Other funds holding EMN

Corient Private Wealth's EMN Position: Q2 2026 in Review

Corient Private Wealth increased its Eastman Chemical (EMN) stake by 13% in Q2 2026, buying an estimated $432K and bringing the position to 50,132 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Corient Private Wealth first reported a position in EMN in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.75M in Q3 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Corient Private Wealth held 50,132 shares of Eastman Chemical worth $3.36M as of Q2 2026.
  • Corient Private Wealth bought 5,902 Eastman Chemical shares in Q2 2026, an estimated $432K.
  • Eastman Chemical made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1069 holding.
  • Corient Private Wealth first reported a position in Eastman Chemical in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Eastman Chemical position peaked at $9.75M in Q3 2024.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.